The DOI matches its Crossref record; 29 of the 30 references it cites were found in a registry or an index.
Epidemiology of Candidaemia in Europe: Results of 28-Month European Confederation of Medical Mycology (ECMM) Hospital-Based Surveillance Study
Abstract
In order to update the epidemiological and mycological profile of candidaemia in Europe, the European Confederation of Medical Mycology conducted a prospective, sequential, hospital population-based study from September 1997 to December 1999. A total of 2,089 cases were documented by 106 institutions in seven European countries. Rates of candidaemia ranging from 0.20 to 0.38 per 1,000 admissions were reported. Candida albicans was identified in 56% of cases. Non-albicans Candida species were most frequently isolated from patients with haematological malignancies (65%). With increasing age, an increasing incidence of Candida glabrata was seen. The 30-day mortality rate was 37.9%. The survey results underline the burden of candidaemia in a wide range of patient populations, confirm the importance of non- albicans species, and provide baseline data for future surveillance studies at a European level.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“While that decreasing trend is ubiquitous, with the series of multicenter European Confederation of Medical Mycology (ECMM) Candida studies showing the proportion of C. albicans causing candidemia decreased from 56.4% in 1997–1999,57 to 54% in 2006–2008,58 to 46.2% in 201856 with corresponding increases in non-albicans species (Table 1), there are important geographic differences.”
From Epidemiology of Invasive Candidiasis (2024) · cites this paper as [57]
In the citing paper
“In a large European study, Tortorano et al. [25] showed that Candida albicans was responsible for more than half of the cases in all patient populations.Candida glabrata was the most frequent non-albicans isolate in surgical (16%) patients.”
From Management of invasive candidiasis and candidemia in adult non-neutropenic intensive care unit patients: part I. Epidemiology and diagnosis (2009) · cites this paper as [25]
Citations
Cites
Ascioglu, S., Rex, J. H., de Pauw, B., Bennett, J. E., Bille, J., Crokaert, F., Denning, D. W., Donnelly, J. P., Edwards, J. E., Erjavec, Z., et al. (2002) · Clinical Infectious Diseases · doi:10.1086/323335 · Cited by 2,331 · cited 1×
“According to the criteria of the European Organization for Research and Treatment of Cancer/Invasive Fungal Infection Group, a single positive blood culture is considered to prove invasive fungal infection [16].”
MethodNosocomial Bloodstream Infections in United States Hospitals: A Three‐Year Analysis
Edmond, M. B., Wallace, S. E., McClish, D. K., Pfaller, M. A., Jones, R. N., & Wenzel, R. P. (1999) · Clinical Infectious Diseases · doi:10.1086/520192 · Cited by 1,387 · cited 1×
“Species of the genus Candida are the agents most frequently implicated in invasive fungal infections, and they now rank as the fourth commonest cause of nosocomial bloodstream infections (BSI) in the USA, accounting for 8–15% of all hospital-acquired sepsis [1, 2].”
BackgroundPractice Guidelines for the Treatment of Candidiasis
Rex, J. H., Walsh, T. J., Sobel, J. D., Filler, S. G., Pappas, P. G., Dismukes, W. E., & Edwards, J. E. (2000) · Clinical Infectious Diseases · doi:10.1086/313749 · Cited by 927 · cited 1×
“Fluconazole was used as the initial antifungal agent in the majority of cases (59%), in agreement with consensus conference guidelines [31].”
ResultHospital-Acquired Candidemia: The Attributable Mortality and Excess Length of Stay
Wey, S. B. (1988) · Archives of Internal Medicine · doi:10.1001/archinte.1988.00380120094019 · Cited by 831 · cited 2×
“The crude mortality rate of these infections is high (40–75%), and the attributable mortality of candidaemia has been estimated at 25–38% [3, 4].”
BackgroundBlumberg, H. M., Jarvis, W. R., Soucie, J. M., Edwards, J. E., Patterson, J. E., Pfaller, M. A., Rangel‐Frausto, M. S., Rinaldi, M. G., Saiman, L., Wiblin, R. T., et al. (2001) · Clinical Infectious Diseases · doi:10.1086/321811 · Cited by 661 · cited 1×
“Besides being raised among the elderly, mortality is particularly high among patients with cancer (49% for solid tumour and 45% for haematological malignancies) and patients undergoing intensive care treatment (42.4%), as reported previously [3, 11, 26 ].”
ResultInfluentialEpidemiology of Nosocomial Fungal Infections, with Emphasis on Candida Species
Jarvis, W. R. (1995) · Clinical Infectious Diseases · doi:10.1093/clinids/20.6.1526 · Cited by 636 · cited 1×
“Species of the genus Candida are the agents most frequently implicated in invasive fungal infections, and they now rank as the fourth commonest cause of nosocomial bloodstream infections (BSI) in the USA, accounting for 8–15% of all hospital-acquired sepsis [1, 2].”
BackgroundViscoli, C., Girmenia, C., Marinus, A., Collette, L., Martino, P., Vandercam, B., Doyen, C., Lebeau, B., Spence, D., Krcmery, V., et al. (1999) · Clinical Infectious Diseases · doi:10.1086/514731 · Cited by 601 · cited 3×
“As already reported [ 11 ], non-albicans Candida spp.”
BackgroundResultInfluentialImportance of Candida Species Other than C. albicans as Pathogens in Oncology Patients
Wingard, J. R. (1995) · Clinical Infectious Diseases · doi:10.1093/clinids/20.1.115 · Cited by 542 · cited 1×
“6%) confirms the importance of these species as causes of BSI, as demonstrated in other surveys [8, 28].”
ResultKao, A. S., Brandt, M. E., Pruitt, W. R., Conn, L. A., Perkins, B. A., Stephens, D. S., Baughman, W. S., Reingold, A. L., Rothrock, G. A., Pfaller, M. A., et al. (1999) · Clinical Infectious Diseases · doi:10.1086/313450 · Cited by 457 · cited 6×
“Most of the epidemiological data on Candida BSI come from studies conducted in the USA [6, 7, 8], whereas European data are typically from small surveys or studies conducted on specific groups of patients or limited to only one country [7, 8, 9, 10, 11, 12].”
ResultInfluentialRevisiting the source of candidemia: skin or gut?
Nucci, M., & Anaissie, E. (2001) · Clinical Infectious Diseases · doi:10.1086/323759 · Cited by 424 · cited 1×
“Our data are compatible with the concept of the gut as the primary source of BSI caused by these species, as expressed in a recent review revisiting the source of candidaemia [27].”
Result
Cited by
Epidemiology of Invasive Candidiasis: a Persistent Public Health Problem
Pfaller, M. A., & Diekema, D. J. (2007) · Clinical Microbiology Reviews · doi:10.1128/cmr.00029-06 · Cited by 4,174
Pappas, P. G., Kauffman, C. A., Andes, D., Benjamin, D. K., Calandra, T. F., Edwards, J. E., Filler, S. G., Fisher, J. F., Kullberg, B.-J., Zeichner, L. O., et al. (2009) · Clinical Infectious Diseases · doi:10.1086/596757 · Cited by 3,191
“The most frequently implicated risk factors include the use of broad-spectrum antibacterial agents, use of central venous catheters, receipt of parenteral nutrition, receipt of renal replacement therapy by patients in ICUs, neutropenia, use of implantable prosthetic devices, and receipt of immunosuppressive agents (in…”
BackgroundEpidemiology and risk factors for invasive candidiasis
Yapar, N. (2014) · Therapeutics and Clinical Risk Management · doi:10.2147/tcrm.s40160 · Cited by 610
“Incidence of IC is higher among infants younger than 1 year old and adults older than 70 years old.(35,50) Patient groups that”
BackgroundColombo, A. L., Nucci, M., Park, B. J., Nouér, S. A., Arthington-Skaggs, B., da Matta, D. A., Warnock, D., & Morgan, J. (2006) · Journal of Clinical Microbiology · doi:10.1128/jcm.00773-06 · Cited by 526
“Half of the ICU case patients had surgery in the 30 days before candidemia, underscoring the importance of surgical procedures and location in the ICU in the epidemiology of candidemia (37, 50).”
BackgroundResultInfluentialInvasive fungal infections: a review of epidemiology and management options
Enoch, D. A., Ludlam, H. A., & Brown, N. M. (2006) · Journal of Medical Microbiology · doi:10.1099/jmm.0.46548-0 · Cited by 501
“Similar results were seen in a prospective pan-European study (Tortorano et al., 2004b).”
BackgroundResult
Metadata
- Authors
- Tortorano, A. M., Peman, J., Bernhardt, H., Klingspor, L., Kibbler, C. C., Faure, O., Biraghi, E., Canton, E., Zimmermann, K., Seaton, S., & Grillot, R.
- Affiliations
- University of Milan (IT)
- Universität Greifswald (DE)
- Karolinska Institutet (SE)
- The Royal Free Hospital (GB)
- Centre Hospitalier Universitaire de Grenoble (FR)
- Corresponding author
- Tortorano, A. M.
- Venue
- European Journal of Clinical Microbiology & Infectious Diseases
- Published
- 2004-04-01
- Volume
- 23
- Issue
- 4
- Pages
- 317-322
- ISSN
- 0934-9723 (ISSN-L)
- 1435-4373
- OpenAlex
- W1974342169
- Cited by
- 509
- References
- 30
- Citations by year
- 2026: 1 · 2025: 7 · 2024: 11 · 2023: 7 · 2022: 15 · 2021: 13 · 2020: 9 · 2019: 11 · 2018: 14 · 2017: 18 · 2016: 17 · 2015: 24 · 2014: 41 · 2013: 34 · 2012: 38
- FWCI
- 17.99
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- European Journal of Clinical Microbiology & Infectious Diseases (publishedVersion)
- PubMed (publishedVersion)
- UCL Discovery (University College London) (submittedVersion)
- Topics
- Health Sciences › Medicine › Infectious Diseases › Antifungal resistance and susceptibility
- Life Sciences › Immunology and Microbiology › Microbiology › Yeasts and Rust Fungi Studies
- Health Sciences › Medicine › Infectious Diseases › Fungal Infections and Studies
- Keywords
- candidemia, Candida albicans, non-albicans Candida, Candida glabrata, hematologic malignancies, incidence, mortality, hospital surveillance, age-related risk, Europe
- MeSH terms
- Adult, Aged, Antifungal Agents, Candida, Candidiasis, Europe, Female, Health Surveys, Humans, Male, Microbial Sensitivity Tests, Middle Aged, Prognosis, Prospective Studies, Risk Factors, Incidence, Survival Rate, Fungemia, Age Distribution, Sex Distribution
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Epidemiology of Candidaemia in Europe: Results of 28-Month European Confederation of Medical Mycology (ECMM) Hospital-Based Surveillance Study. https://app.cochat.ai/papers/10.1007/s10096-004-1103-y
- The paper
- Tortorano, A. M., Peman, J., Bernhardt, H., Klingspor, L., Kibbler, C. C., Faure, O., Biraghi, E., Canton, E., Zimmermann, K., Seaton, S., & Grillot, R. (2004). Epidemiology of Candidaemia in Europe: Results of 28-Month European Confederation of Medical Mycology (ECMM) Hospital-Based Surveillance Study. European Journal of Clinical Microbiology & Infectious Diseases. https://doi.org/10.1007/s10096-004-1103-y
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.